Abstract
Binding affinity prediction is one of the most critical components to computer-aided structure-based drug design. Despite advances in first-principle methods for predicting binding affinity, empirical scoring functions that are fast and only relatively accurate are still widely used in structure-based drug design. With the increasing availability of X-ray crystallographic structures in the Protein Data Bank and continuing application of biophysical methods such as isothermal titration calorimetry to measure thermodynamic parameters contributing to binding free energy, sufficient experimental data exists that scoring functions can now be derived by separating enthalpic (ΔH) and entropic (TΔS) contributions to binding free energy (ΔG). PHOENIX, a scoring function to predict binding affinities of protein-ligand complexes, utilizes the increasing availability of experimental data to improve binding affinity predictions by the following: model training and testing using high-resolution crystallographic data to minimize structural noise, independent models of enthalpic and entropic contributions fitted to thermodynamic parameters assumed to be thermodynamically biased to calculate binding free energy, use of shape and volume descriptors to better capture entropic contributions. A set of 42 descriptors and 112 protein-ligand complexes were used to derive functions using partial least squares for change of enthalpy (ΔH) and change of entropy (TΔS) to calculate change of binding free energy (ΔG), resulting in a predictive r2 (r2pred) of 0.55 and a standard error (SE) of 1.34 kcal/mol. External validation using the 2009 version of the PDBbind “refined set” (n = 1612) resulted in a Pearson correlation coefficient (Rp) of 0.575 and a mean error (ME) of 1.41 pKd. Enthalpy and entropy predictions were of limited accuracy individually. However, their difference resulted in a relatively accurate binding free energy. While the development of an accurate and applicable scoring function was an objective of this study, the main focus was evaluation of the use of high-resolution X-ray crystal structures with high-quality thermodynamic parameters from isothermal titration calorimetry for scoring function development. With the increasing application of structure-based methods in molecular design, this study suggests that using high-resolution crystal structures, separating enthalpy and entropy contributions to binding free energy, and including descriptors to better capture entropic contributions may prove to be effective strategies towards rapid and accurate calculation of binding affinity.
INTRODUCTION
Predicting binding affinity is one of the most critical and challenging components to computer-aided structure-based drug design.1,2 Methods for predicting binding affinity are instrumental in a variety of applications, including molecular docking to identify a native binding mode, virtual screening of compound libraries to identify lead compounds, and lead optimization for enhancing binding affinity and target specificity.3-5 Despite significant advances in first-principle methods for predicting binding affinity6-10, empirical scoring functions that are fast and relatively accurate are still widely used in drug discovery.11 For virtual screening studies where libraries up to millions of compounds are screened against a target of interest, a scoring function is needed to rapidly assess multiple binding modes of each multiple conformers generated for each compound. This is also the case for in silico lead optimization where a large number of analogs are computationally constructed and assessed. In addition to speed of evaluation for virtual screening, other scoring functions can be accurate at an atomic level for structure-based drug design in characterizing the dominant physical forces in molecular recognition during ligand binding. Moreover, empirical scoring functions should be transferable and not require careful individual validation for each system under study, making them more suitable for use in new problems with limited experimental data.
Empirical scoring functions aim to represent the atomic interactions of protein-ligand complexes by the use of relatively simple quantitative descriptors to capture the physicochemical forces governing protein-ligand complex formation. The underlying assumption in scoring functions is that the physical and chemical interactions of protein-ligand interactions can be quantitatively captured using a set of descriptors, and the sum of these descriptors will accurately predict binding affinities. In practice, each descriptor is weighted by a coefficient, derived by a linear regression method through training on experimental data from binding assays, resulting in an equation for calculating binding affinities. Over the last 20 years, a number of scoring functions have been developed, with some notable ones being SCORE112, SCORE213, ChemScore14, X-Score15, Lig-Score16, DrugScore17, CScore18, GOLD19,20, PLP21, and SFCscore22. These scoring functions differ by their choice and implementation of descriptors to capture the physicochemical interactions, the size and diversity of the training set, and the regression method used to derive the predictive equations. A number of reviews on scoring functions and assessments of their performance and applicability have been published.23-29
Empirical scoring functions generally predict either the free energy of binding (ΔG) or the dissociation constant (Kd), each of which can be derived from the other. Recent calorimetric studies have elucidated the compensating enthalpic and entropic changes associated with binding free energy.30-33 In a review from Ladbury, Klebe, and Freire, the binding free energies of first-in-class HIV-1 protease and HMG-CoA reductase inhibitors were shown to be due largely from optimizing entropy (ΔS), while improving binding affinity of subsequent analogs was predominantly the result of improving enthalpy (ΔH).34 Marlow et al. has experimentally demonstrated that changes in protein conformational dynamics can serve as an indication of the changes in protein conformation entropy, which may also play an important role in high-affinity protein-ligand complexes.35 Roy and Laughton have demonstrated using molecular dynamics simulations the importance of phenomena such as entropy-entropy compensation, dewetting of the protein binding site, and ligand configuration entropy in the form of rotational freedom in contributing to changes in entropy.36 Because the binding free energy is composed of these compensating thermodynamics forces, the ability to accurately predict enthalpy (ΔH) and entropy (TΔS) independently should provide additional insight during structure-based drug design studies. Results from these experimental and theoretical studies illustrate the importance of considering both enthalpy and entropy contributions separately and in a greater detail for structure-based drug design studies.
Current empirical scoring functions contain descriptors that mainly take into account the changes of enthalpy (ΔH) in binding, and have used rudimentary methods such as the number of rotamers on a ligand, calculated partition coefficient (XlogP), and complementary hydrophobic surface area estimation to describe changes in entropic forces (TΔS). The lack of an accurate entropic description of protein-ligand interactions is surely the major reason why scoring function accuracy has been limited; they can predict enthalpic contributions accurately, but fail to predict entropic contributions, resulting in limited accuracy in predicting binding free energy. In the development of PHOENIX, addition terms to describe the shape and volume of both the ligand and protein binding site were included to implicitly capture the desolvation and ligand expulsion of solvent from the binding site contributing to entropic changes. Volume-based descriptors may also heuristically capture the rotational and translation entropy contributing to the configurational entropy of the system. Developing entropy models using shape and volume-based descriptors should lead to more accurate binding affinity predictions.
Development of PHOENIX aimed to take advantage of the increasing application of isothermal titration calorimetry (ITC) in medicinal chemistry and the recent availability of databases (PDBcal37 and SCORPIO38) containing both X-ray crystallographic structures of protein-ligand complexes and ITC experimental determination of both enthalpic and entropic contributions to binding free energy. PHOENIX, derived from the VALIDATE39 scoring function, includes additional shape and volume-based descriptors to better capture entropic contributions typically not accounted for in scoring functions. A diverse set of 112 protein-ligand complexes with resolution ≤ 2.0 Å and thermodynamics parameters measured from ITC was used for training. A set of 42 descriptors, including 7 shape and volume descriptors calculated using FPOCKET40, were used as a heutistic method to capture the physicochemical forces underlying protein-ligand interactions. Partial least squares of latent variables (PLS) was used to assign coefficients for each descriptor, and to independently derive regression equations to calculate ΔH and TΔS.
METHODS
Training Set
Information on protein-ligand complexes with crystallographic structures and thermodynamic parameters from isothermal titration calorimetry were obtained from PDBcal37 and SCORPIO38 databases. Experimental values of ΔG, ΔH, and TΔS were obtained from the database websites (http://www.pdbcal.org and http://scorpio.biophysics.ismb.lon.ac.uk/scorpio.html), while X-ray crystallographic structures were downloaded from the Protein Data Bank (PDB). Only structures of complexes with a crystallographic resolution ≤2.5 Å were used in the intial compilation of the training set. Additional metrics such as free R value (Rfree)41 and diffraction-component precision index (DPI)42 were used to assess structural quality. Rfree is a measure of the degree to which an atomic model predicts a subset of the observed diffraction data that has been omitted from the refinement process (see Supporting Information for equation). DPI is a measure of the quality of the structural model derived from the diffraction data (see Supporting Information for equation). However, due the to scarcity of complexes with a resolution of ≤2.5 Å, ITC parameters, and Rfree values, the resolution (≤2.0 Å) was used as the final criteria to obtain the PHOENIX training set of 112 complexes. Nine different subsets of the 162 complexes were evaluated for predictive ability: Set 68, includes structures with resolutions ≤2.0 Å, Rfree ≤0.3, DPI ≤0.3, ligand molecular weight <1000 daltons, ΔH, TΔS; Set 82, includes structures with resolutions ≤2.0 Å, Rfree ≤0.3, DPI ≤0.3, ligand molecular weight <1000 daltons; Set 91, includes structures with resolutions ≤2.0 Å, Rfree ≤0.3, DPI ≤0.3; Set 105, includes structures with resolutions ≤2.0 Å, ligand molecular weight <1000 daltons; Set 112, includes structures with resolutions ≤2.0 Å; Set 127, includes structures with resolutions ≤2.0 Å, 15 complexes with resolution between 2.0 and 2.5 Å also present in PDBbind test set; Set 140, includes structures with resolutions ≤2.25 Å; Set 153, includes structures with resolutions ≤2.5 Å, ligand molecular weight <1000 daltons; Set 162, includes structures with resolutions ≤2.5 Å. These subsets were selected to evaluate whether the quality of the crystal structures and diversity of the training set impacted the performance of the scoring function. Of the 9 subsets tested, Set 112 (Table 3) (resolutions ≤2.0 Å) resulted in the best performing binding free energy (ΔG) model.
Table 3.
A. | |||||
---|---|---|---|---|---|
Scoring Function | Number of Complexes |
Number of Components |
Correlation Coefficient (r2) |
Standard Error (s) (kcal/mol) |
F-value (F) |
PHOENIX_DH_68 | 68 | 3 | 0.645 | 4.03 | 38.69 |
PHOENIX_DH_82 | 82 | 4 | 0.566 | 6.1 | 25.09 |
PHOENIX_DH_105 | 105 | 2 | 0.442 | 6.79 | 40.44 |
PHOENIX_DH_112 | 112 | 3 | 0.497 | 6.44 | 35.6 |
PHOENIX_DH_127 | 127 | 3 | 0.503 | 6.24 | 41.44 |
PHOENIX_DH_140 | 140 | 3 | 0.447 | 6.37 | 36.64 |
PHOENIX_DH_153 | 153 | 4 | 0.48 | 6.22 | 34.15 |
PHOENIX_DH_162 | 162 | 4 | 0.466 | 6.26 | 34.3 |
B. | |||||
---|---|---|---|---|---|
Scoring Function | Number of Complexes |
Number of Components |
Correlation Coefficient (r2) |
Standard Error (s) (kcal/mol) |
F-value (F) |
PHOENIX_TDS_68 | 68 | 3 | 0.735 | 3.81 | 59.2 |
PHOENIX_TDS_82 | 82 | 5 | 0.722 | 4.92 | 39.45 |
PHOENIX_TDS_105 | 105 | 2 | 0.55 | 6.06 | 62.26 |
PHOENIX_TDS_112 | 112 | 3 | 0.605 | 5.69 | 55.17 |
PHOENIX_TDS_127 | 127 | 3 | 0.606 | 5.63 | 63.01 |
PHOENIX_TDS_140 | 140 | 2 | 0.478 | 6.29 | 62.7 |
PHOENIX_TDS_153 | 153 | 3 | 0.512 | 6.2 | 52.1 |
PHOENIX_TDS_162 | 162 | 3 | 0.534 | 6.03 | 60.29 |
C. | |||
---|---|---|---|
Scoring Function | Number of Complexes |
Predictive r2 (r2pred) |
Standard Error (s) (kcal/mol) |
PHOENIX_DG_68 | 68 | 0.61 | 1.19 |
PHOENIX_DG_82 | 82 | −7.00 | 5.54 |
PHOENIX_DG_105 | 105 | 0.43 | 1.55 |
PHOENIX_DG_112 | 112 | 0.55 | 1.34 |
PHOENIX_DG_127 | 127 | 0.44 | 1.44 |
PHOENIX_DG_140 | 140 | −0.89 | 2.62 |
PHOENIX_DG_153 | 153 | −0.13 | 2.01 |
PHOENIX_DG_162 | 162 | 0.30 | 1.56 |
Structure Preparation
Protein-ligand complexes downloaded from the PDB were prepared as follows. Protein structure was extracted from the complex using SYBYL 7.3. Water molecules present in the complex were kept as part of the protein structure for an explicit solvent representation. In cases where multiple chains or subunits were present, the chain or subunit that was most complete was selected, which was chain A in most cases. Missing side chains and neutral terminal groups were added by the Biopolymer Structure Preparation function. Hydrogens were added to both the protein and water using the Biopolymer dictionary. The ligand was extracted from the complex and atom types were assessed and reassigned, if necessary. Hydrogens were added to all atoms. The resulting protein and ligand structures were saved in mol2 format.
External Test Sets
External validation sets include three versions of the PDBbind “refined set” (2002, 2004, and 2009)43,44 and the 2007 PDBbind “core set” downloaded from the PDBbind site (http://www.pdbbind.org.cn/). Previous scoring function development studies by Wang, Lu, Fang, and Wang.26 and Sotriffer, Sanschagrin, Matter, and Klebe.22 used both the 2002 and 2004 versions as benchmark sets, thus were assessed in this study for comparison purposes. The 2002 version contains 800 complexes, the 2004 version contains 1091 complexes, and the 2009 version contains 1741 protein-ligand complexes with resolution ≤2.5 Å. The 2007 “core set”, which consists of 195 complexes with non-redundant protein families and diversity of ligand structures and binding affinities, was also used to assess the general applicability of PHOENIX. A number of docking and scoring assessments have used this “core set” as a diverse set benchmark.29 The protein and ligand structures were downloaded from the PDBbind database. Structures of the proteins were prepared using the same procedure as the training set. The ligands did not require any preparation and were used as is. For the 2004 and 2009 sets, 1071 out of 1091 were used in the 2004 set, while 1612 of 1741 were used in the 2009 set.
Descriptor Set
A set of 42 descriptors were used to derive the PHOENIX scoring function, as listed in Table 1. Of that set, the first 34 of the descriptors listed were calculated using the VALIDATE scoring function39. The calculated partition coefficient, XlogP, was computed based on the Wang, Fu, and Lai45 study using FILTER46. FPOCKET40, a cavity detection program based on Voronoi tessellation and alpha spheres, was used to obtain 7 volume-based descriptors to describe the ligand and protein binding site.
Table 1.
Descriptor | ΔH | TΔS | ΔG |
---|---|---|---|
INTERCEPT | −7.064 | −1.619 | −5.445 |
Electrostatic Interaction Energy | −0.006 | −0.005 | −0.001 |
Steric Interaction Energy | 0.008 | 0.004 | 0.004 |
Steric Fit | −0.064 | −0.085 | 0.021 |
Rotatable Bonds | 0.002 | 0.001 | 0.001 |
Ligand Strain Energy | 0.023 | 0.008 | 0.015 |
Hydrophobic/Hydrophobic Contact Surface Area 1 | 0.004 | 0.007 | −0.003 |
Hydrophilic/Hydrophilic Contact Surface Area 1 (Opposite Charge) | 0.009 | 0.011 | −0.002 |
Hydrophobic/Hydrophilic Contact Surface Area 1 | 0.009 | 0.012 | −0.003 |
Hydrophilic/Hydrophilic Contact Surface Area 1 (Same Charge) | 0.006 | 0.011 | −0.005 |
Hydrophobic/Hydrophobic Contact Surface Area 2 | 0.001 | 0.001 | 0 |
Hydrophilic/Hydrophilic Contact Surface Area 2 (Opposite Charge) | 0.006 | 0.006 | 0 |
Hydrophobic/Hydrophilic Contact Surface Area 2 | 0.003 | 0.004 | −0.001 |
Hydrophilic/Hydrophilic Contact Surface Area 2 (Same Charge) | −0.002 | 0 | −0.002 |
Ligand Total Hydrophobic Surface Area | 0 | 0.001 | −0.001 |
Ligand Total Hydrophilic Surface Area | −0.003 | −0.004 | 0.001 |
Flexibility Index(Rot Bonds/ Non Term Bonds) | 3.549 | 3.424 | 0.125 |
Ligand Buried Hydrophobic Surface Area | 0 | 0.001 | −0.001 |
Ligand Buried Hydrophilic Surface Area | −0.006 | −0.006 | 0 |
Ligand Exposed Hydrophobic Surface Area | −0.001 | −0.001 | 0 |
Ligand Exposed Hydrophilic Surface Area | −0.003 | −0.004 | 0.001 |
Receptor Buried Hydrophobic Surface Area | −0.001 | 0.001 | −0.002 |
Receptor Buried Hydrophilic Surface Area | −0.002 | 0.002 | −0.004 |
Receptor Exposed Hydrophobic Surface Area | 0 | 0 | 0 |
Receptor Exposed Hydrophilic Surface Area | 0 | 0 | 0 |
Normalized Ligand Buried Hydrophobic Surface Area | 3.487 | 3.695 | −0.208 |
Normalized Ligand Buried Hydrophilic Surface Area | −2.814 | −2.906 | 0.092 |
Normalized Ligand Exposed Hydrophobic Surface Area | −4.324 | −3.101 | −1.223 |
Normalized Ligand Exposed Hydrophilic Surface Area | −2.993 | −5.661 | 2.668 |
Total Ligand/Receptor Hydrogen Bonds | 0.044 | 0.032 | 0.012 |
Ligand Total Donor/Acceptor Count | −0.059 | −0.072 | 0.013 |
Ligand Total Hydrogen Bond Atoms | 0.007 | −0.008 | 0.015 |
Ligand Total Buried Donor/Acceptor Count | −0.114 | −0.129 | 0.015 |
Receptor Total Donor/Acceptor Count | 0.053 | 0.045 | 0.008 |
Receptor Total Buried Donor/Acceptor Count | 0.079 | 0.082 | −0.003 |
Partition Coefficient | 0.024 | 0.115 | −0.091 |
Ligand Volume | −0.001 | −0.001 | 0 |
Pocket Volume | −0.001 | −0.001 | 0 |
Number of Alpha Spheres | 0.004 | 0.009 | −0.005 |
Proportion of Apolar Alpha Spheres | −4.253 | −4.039 | −0.214 |
Mean Local Hydrophobic Density | −0.159 | −0.137 | −0.022 |
Polarity Score | 0.124 | 0.114 | 0.01 |
Alpha Sphere Density | 0.012 | −0.019 | 0.031 |
VALIDATE parameters were determined by using both molecular mechanics a heuristics approach in combination with parameters derived from molecular mechanics. Parameters derived from molecular mechanics include electrostatic interaction energy (EIE), steric interaction energy (SIE), and ligand strain energy (LSE). EIE accounts for the electrostatic interactions that contribute to the specificity of protein-ligand interactions, and was calculated using the MacroModel program. Charges for the protein and ligand were derived from the OPLS-AA force field. Nonbonded electrostatic interaction energy was calculated using the explicit sum of the Coulombic potentials. SIE was computed from the explicit sum of the Lennard-Jones potentials, where the required parameters were derived from the OPLS-AA force field. LSE was calculated based on the difference between the energy of the ligand in the binding site and the energy of the ligand by itself.
Descriptors derived from heuristics for both the ligand and protein include steric fit, number of rotatable bonds, total number of ligand/protein hydrogen bonds, total donor/acceptor count, total hydrogen-bond atoms, and number of buried hydrogen-bond atoms. Steric fit (SF) was used to describe the close packing interactions between the protein and ligand. In order to quantitate surface complementarity between protein and ligand, descriptors were used to capture lipophilic complementarity (nonpolar/nonpolar), hydrophilic complementarity (polar/polar, opposite charge), lipophilic/hydrophilic complementarity (polar/nonpolar), and hydrophilic noncomplementarity (polar/polar, like charge). Two separate methods were used. The first method used an absolute surface area between the protein and ligand similar to the method used by Bohm12. The second method was based on a pairwise sum estimate, similar to the approach by Kellogg et al47. For a detailed description of the implementation and underlying theory of the 34 VALIDATE descriptors, refer to the original study by Head et al.39
As a heuristic method to capture entropic contributions, volume descriptors were used to represent the amount of water molecules displaced from the protein binding site, as well as the desolvation process of ligand going from unbound to bound state. FPOCKET40, a cavity detection program based on Voronoi tessellation and alpha spheres, was used to obtain 7 volume-based descriptors to describe the ligand and protein binding site (ligand volume, pocket volume, number of alpha spheres, proportion of apolar alpha spheres, mean local hydrophobic density, polarity score, alpha sphere density).
Feature selection strategies such as excluding descriptors with a correlation coefficient ≥0.95 of another descriptor, or excluding descriptors that displayed minimal correlation to the thermodynamics parameters (≤0.01, ≤0.05) were assessed to identify a set of descriptors leading to the best performance. In addition, attempts were made to separate ΔH and TΔS descriptors by deriving simpler models using subsets (n = 20-30) of the final descriptors set (n = 42) which contribute qualitatively to each thermodynamic force, to test if more accurate predictions could be achieved. After excluding the descriptors with high correlation and descriptors with low correlation to ΔH and TΔS as well as separating descriptors for each thermodynamic force, the models resulted in less accurate predictions when assessing the 2002 version of PDBbind; therefore all 42 descriptors were used in as the PHOENIX scoring function.
Function Parameterization
The weight coefficients for each descriptor and equation for predicting ΔH and TΔS were derived by using PLS in SYBYL 7.3. All 42 descriptors were used as input parameters. To derive the regression equations, leave-one-out cross validation was initially performed to identify the optimal number of components to use for the PLS model. The PLS model was subsequently constructed using the number of components with the highest q2 and least error to calculate the constant and coefficients for each descriptor. Regression statistics such as r2, standard error, and F-value were used to assess the predictive ability of the models. The fraction of relative contribution of each descriptor to change in enthalpy (ΔH), change in entropy (TΔS), and change in binding free energy (ΔG) is listed in Table 2, and the coefficients and intercepts derived from partial least squares regression for the final PHOENIX scoring function (n = 112) are listed in Table 3.
Table 2.
Descriptor | ΔH | TΔS | ΔG |
---|---|---|---|
Mean Local Hydrophobic Density | 0.08 | 0.063 | 0.072 |
Flexibility Index (Rot Bonds/ Non Term Bonds) | 0.066 | 0.059 | 0.063 |
Receptor Total Buried Donor/Acceptor Count | 0.063 | 0.061 | 0.062 |
Pocket Volume | 0.052 | 0.051 | 0.052 |
Electrostatic Interaction Energy | 0.054 | 0.043 | 0.049 |
Hydrophobic/Hydrophilic Contact Surface Area 2 | 0.043 | 0.049 | 0.046 |
Proportion of Apolar Alpha Spheres | 0.049 | 0.043 | 0.046 |
Hydrophobic/Hydrophilic Contact Surface Area 1 | 0.04 | 0.049 | 0.045 |
Polarity Score | 0.048 | 0.04 | 0.044 |
Normalized Ligand Buried Hydrophobic Surface Area | 0.035 | 0.034 | 0.035 |
Ligand Total Donor/Acceptor Count | 0.031 | 0.035 | 0.033 |
Ligand Buried Hydrophilic Surface Area | 0.034 | 0.03 | 0.032 |
Ligand Total Buried Donor/Acceptor Count | 0.031 | 0.032 | 0.032 |
Ligand Total Hydrophilic Surface Area | 0.029 | 0.028 | 0.029 |
Ligand Strain Energy | 0.04 | 0.014 | 0.027 |
Steric Interaction Energy | 0.035 | 0.016 | 0.026 |
Normalized Ligand Buried Hydrophilic Surface Area | 0.026 | 0.025 | 0.026 |
Hydrophilic/Hydrophilic Contact Surface Area 2 (Opposite Charge) |
0.024 | 0.023 | 0.024 |
Hydrophilic/Hydrophilic Contact Surface Area 1 (Opposite Charge) |
0.02 | 0.024 | 0.022 |
Hydrophobic/Hydrophobic Contact Surface Area 1 | 0.015 | 0.025 | 0.02 |
Hydrophilic/Hydrophilic Contact Surface Area 1 (Same Charge) | 0.014 | 0.024 | 0.019 |
Ligand Volume | 0.021 | 0.015 | 0.018 |
Receptor Exposed Hydrophobic Surface Area | 0.013 | 0.02 | 0.017 |
Normalized Ligand Exposed Hydrophilic Surface Area | 0.012 | 0.021 | 0.017 |
Normalized Ligand Exposed Hydrophobic Surface Area | 0.019 | 0.013 | 0.016 |
Receptor Exposed Hydrophilic Surface Area | 0.009 | 0.02 | 0.015 |
Ligand Exposed Hydrophilic Surface Area | 0.011 | 0.015 | 0.013 |
Receptor Total Donor/Acceptor Count | 0.015 | 0.011 | 0.013 |
Partition Coefficient | 0.005 | 0.021 | 0.013 |
Hydrophobic/Hydrophobic Contact Surface Area 2 | 0.007 | 0.016 | 0.012 |
Total Ligand/Receptor Hydrogen Bonds | 0.013 | 0.009 | 0.011 |
Receptor Buried Hydrophilic Surface Area | 0.008 | 0.011 | 0.01 |
Ligand Buried Hydrophobic Surface Area | 0.004 | 0.013 | 0.009 |
Number of Alpha Spheres | 0.005 | 0.012 | 0.009 |
Receptor Buried Hydrophobic Surface Area | 0.006 | 0.009 | 0.008 |
Steric Fit | 0.006 | 0.007 | 0.007 |
Ligand Exposed Hydrophobic Surface Area | 0.008 | 0.004 | 0.006 |
Ligand Total Hydrophobic Surface Area | 0.001 | 0.008 | 0.005 |
Hydrophilic/Hydrophilic Contact Surface Area 2 (Same Charge) | 0.007 | 0.001 | 0.004 |
Ligand Total Hydrogen Bond Atoms | 0.002 | 0.002 | 0.002 |
Alpha Sphere Density | 0.001 | 0.002 | 0.002 |
Rotatable Bonds | 0.001 | 0.001 | 0.001 |
RESULTS
Regression Analysis
Regression and leave-one-out cross validation statistics of the different training sets used for PHOENIX are listed in Table 3, along with statistics for change of enthalpy (Table 3A), change in entropy (Table 3B), and change in binding free energy (Table 3C). Although the training set of 68 complexes resulted in the best regression statistics and standard errors, equations derived using the training set of 112 complexes were used since its performance on the external test sets were better than ones using the other test sets. Selecting the training set with the best regression or cross-validations statistics to use for external predictions can lead to using a model that may simply be overfitted to the training set. Regression analysis on the different training sets demonstrated that good fits were obtained using partial least squares on the set of 42 descriptors. Figure 2 shows the experimental versus predicted values of change of enthalpy (ΔH) (Figure 2A), change of entropy (TΔS) (Figure 2B), and change of binding free energy (ΔG) (Figure 2C).
The training set with 112 complexes resulted in models that did not lead to good regression statistics compared with results using the training set of 68 complexes. One possible reason for this is the larger training set contained a wider variety of protein-ligand complexes, especially ones that were difficult to predict, such as streptavidin and biotin complexes. Change in enthalpy and change in entropy values did not vary as much in the set of 68 complexes as the larger training sets, resulting in smaller errors and a better linear fit. However, when validating the model on external test sets such as PDBbind, enthalpy, and entropy, and binding free energy regression equations derived using the set of 112 complexes resulted in better regression statistics, which indicates that diversity in both structural data and thermodynamics data may be necessary to achieve robust predictive ability. When tested using the larger training sets (n = 127, 140, 153, 162) which included structures between 2 and 2.5 Å resolution, the performance on the external test sets did not improve. While increasing the size of the training set generally leads to more predictive models, in this case, results from this study suggest that inclusion of lower-resolution structures may actually introduce noise, leading to less predictive binding affinity calculations.
Internal cross-validation
Cross-validation studies were performed on the PHOENIX scoring function trained with 112 complexes. The set of 112 complexes was divided into a set of 82 complexes for training, and a set of 30 complexes for testing. PLS was used to derive regression equations, which resulted in the following regression and leave-one-out cross validation statistics: r2 = 0.43, s = 7.27 kcal/mol (2 components), q2 = 0.34, SPRESS = 7.83 kcal/mol for change of enthalpy (ΔH); r2 = 0.56, s = 6.37 kcal/mol (2 components), q2 = 0.48, SPRESS = 6.89 kcal/mol for change of entropy (TΔS). These equations were used to calculate the thermodynamics contributions in the test set. Figure 3 displays the experimental versus predicted values for ΔH, TΔS, and ΔG. Predicted statistics for the test set of 30 complexes were as follows: ΔH, r2 = 0.25, s = 6.32 kcal/mol; TΔS, r2 = 0.31, s = 6.01 kcal/mol; ΔG, r2 = 0.52, s = 1.53 kcal/mol. While the ΔH and TΔS calculations resulted in sizable errors, calculating their difference to obtain binding free energy led to a standard error within a reasonable accuracy range.
Testing on external data sets
To better assess the performance of PHOENIX on accuracy and applicability of affinity predictions, the scoring function trained with 112 complexes was tested on 4 different versions (2002, 2004, and 2009 refined sets; 2007 core set) of the PDBbind. For the sake of comparison, the assessment was performed in a similar fashion to the scoring function studies of Wang, Lu, Fang, and Wang,26 Sotriffer, Sanschagrin, Matter, and Klebe,22 and Cheng, Li, Li, Liu, and Wang29. Note the use of a different set of statistical metrics (e.g., Pearson correlation coefficient, Spearman correlation coefficient, etc.) to assess the performance on the external data set for comparison purposes with previous scoring function studies. To assess the performance of PHOENIX in a greater detail, correlation evaluation was performed on protein-ligand complexes categorized based on resolutions, protein families, and binding affinities in the 2002 version. The 2004 and 2009 refined sets were used to assess the performance of PHOENIX on larger and more diverse data sets. The 2007 core set, consisting of 195 complexes with 65 protein families with 3 ligands of different affinities (low-, medium-, and high-affinity), was used to assess performance on a non-redundant and diverse set of complexes.
Correlation evaluation results for the 2002 version of PDBbind compared to scoring functions in the Wang, Lu, Fang, and Wang study and SFCscore are summarized in Table 4. Based on the correlation evaluation of PDBbind 2002, the performance of PHOENIX is comparable to the top-performing scoring functions (e.g., SFCscore and X-Score::HMScore).
Table 4.
Scoring Function |
Rp | Rs | SD | ME | a | b |
---|---|---|---|---|---|---|
PHOENIX_68 | 0.499 | 0.518 | 2.04 | 1.62 | 0.33 | 4.09 |
PHOENIX_82 | 0.41 | 0.449 | 6.27 | 5.94 | 0.38 | 8.34 |
PHOENIX_105 | 0.473 | 0.502 | 2.06 | 1.6 | 0.43 | 3.25 |
PHOENIX_112 | 0.524 | 0.559 | 1.98 | 1.56 | 0.37 | 4.27 |
PHOENIX_127 | 0.517 | 0.534 | 2.07 | 1.65 | 0.33 | 4.77 |
PHOENIX_140 | 0.424 | 0.445 | 2.91 | 2.41 | 0.41 | 2.32 |
PHOENIX_153 | 0.333 | 0.339 | 2.24 | 1.81 | 0.21 | 4.54 |
PHOENIX_162 | 0.492 | 0.513 | 2.17 | 1.72 | 0.34 | 3.62 |
Resolutions
To assess the performance of PHOENIX on affinity predictions for low- and high-resolution complexes, the 2002 version of PDBbind was categorized into 2 sets: a high-resolution (≤2Å) set of 494 complexes, and a low-resolution (2 ≤ 2.5 Å) set of 302 complexes. Correlation evaluation results are listed in Table 6. PHOENIX affinity predictions on the high-resolution set were comparable to ones obtained from the X-Score functions (HPScore, HMScore, HSScore). PHOENIX affinity predictions on the low-resolution set were inferior to ones obtained from the 3 X-Score functions. PHOENIX, as well as the X-Score functions, provided better correlation statistics for the high-resolution set than the low-resolution set. One point to note is that the high-resolution set has 192 more complexes compared to the low-resolution set, yet still achieved better correlation statistics. These results may suggest that scoring functions in general can achieve more accurate predictions using higher-resolution and perhaps higher-quality X-ray crystal structures compared to using low-resolution and low-quality structures.
Table 6.
High (0 ≤ 2 Å) | Low (2 ≤ 2.5 Å) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Scoring Function | N | Rp | SD | ME | Rs | N | Rp | SD | ME | Rs |
PHOENIX | 494 | 0.558 | 1.92 | 1.52 | 0.586 | 302 | 0.468 | 2.06 | 1.60 | 0.511 |
X-Score::HPScore | 494 | 0.597 | 1.95 | 1.55 | 0.615 | 302 | 0.492 | 2.13 | 1.68 | 0.525 |
X-Score::HMScore | 494 | 0.575 | 2.03 | 1.62 | 0.589 | 302 | 0.480 | 2.19 | 1.73 | 0.525 |
X-Score::HSScore | 494 | 0.614 | 1.89 | 1.49 | 0.640 | 302 | 0.493 | 2.07 | 1.62 | 0.536 |
Protein Families
Three protein families were selected from the 2002 version of PDBbind set to test the performance of PHOENIX on these special cases: HIV-1 protease, trypsin, carbonic anhydrase II. Table 7 lists the correlation evaluation statistics. The correlation statistics from PHOENIX on the HIV-1 protease set (Rp = 0.563, SD = 1.65, ME = 1.35, Rs = 0.434) is better than most of the scoring functions in the Wang, Lu, Fang, and Wang study in terms of Rp, and comparable to the top-performing scoring functions (Cerius2::LigScore, Rp = 0.528; GOLD::GoldScore_opt, Rp = 0.555). This may be due to the inclusion of explicit waters in PHOENIX; water molecules play a critical role in the binding of HIV-1 protease inhibitors. For the trypsin complexes, the correlation statistics from PHOENIX were inferior compared to the other scoring functions tested. Perhaps, the descriptors used in PHOENIX cannot adequately capture the electrostatics involved in the binding of trypsin inhibitors due to the use of monopole electrostatics, which led to larger errors in the affinity calculations. Another potential reason for the poorer performance is that only 2 trypsin complexes were included in the PHOENIX training set, while other scoring functions included a larger set of trypsin complexes in their training sets. As the availability of crystal structure of complexes with ITC data increases, more trypsin complexes can be included in the training set to improve affinity calculations. For the set of carbonic anhydrase II complexes, the correlation statistics from PHOENIX were comparable to the other scoring functions. SFCscore performed the best, which may primarily be due to the descriptors used to capture interactions with metal atoms present in the binding pocket; metals are involved in critical interactions with the ligand for this class of metalloenzymes. Inferior performance in affinity predictions for the carbonic anydrase set may be due to the fact that PHOENIX does not contain any descriptors to capture ligand interactions with metal atoms. Again, the use of more sophisticated representation of electrostatic interactions should improve predictability.
Table 7.
HIV-1 Protease | Trypsin | Carbonic Anhydrase II | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Scoring Function | N | Rp | SD | ME | Rs | N | Rp | SD | ME | Rs | N | Rp | SD | ME | Rs |
8 | 1.6 | 1.3 | 4 | 1.9 | 1.3 | 3 | 3.2 | 2.9 | |||||||
PHOENIX | 2 | 0.563 | 5 | 5 | 0.434 | 0 | 0.476 | 0 | 8 | 0.574 | 9 | 0.539 | 6 | 7 | 0.444 |
7 | 4 | 3 | |||||||||||||
SFSscore::met | 4 | 0.361 | na | na | 0.312 | 0 | 0.853 | na | na | 0.848 | 7 | 0.717 | na | na | 0.485 |
8 | 1.2 | 1.0 | 4 | 1.1 | 0.8 | 3 | 1.1 | 0.8 | |||||||
X-Score::HPScore | 2 | 0.429 | 5 | 1 | 0.436 | 5 | 0.754 | 5 | 8 | 0.725 | 9 | 0.544 | 8 | 5 | 0.547 |
8 | 1.2 | 1.0 | 4 | 0.9 | 0.7 | 3 | 1.2 | 0.9 | |||||||
X-Score::HMScore | 2 | 0.379 | 8 | 4 | 0.334 | 5 | 0.823 | 9 | 5 | 0.824 | 9 | 0.495 | 3 | 5 | 0.341 |
8 | 1.2 | 1.0 | 4 | 1.1 | 0.9 | 3 | 1.2 | 0.9 | |||||||
X-Score::HSScore | 2 | 0.400 | 7 | 5 | 0.322 | 5 | 0.753 | 5 | 1 | 0.766 | 9 | 0.417 | 8 | 1 | 0.448 |
8 | 1.2 | 1.0 | 4 | 1.0 | 0.8 | 3 | 1.1 | 0.8 | |||||||
DrugScore::Pair | 2 | 0.377 | 8 | 4 | 0.315 | 5 | 0.780 | 9 | 2 | 0.818 | 9 | 0.622 | 0 | 3 | 0.501 |
8 | 1.2 | 1.0 | 4 | 1.2 | 0.9 | 3 | 1.2 | 0.9 | |||||||
DrugScore::Surf | 2 | 0.401 | 7 | 2 | 0.317 | 5 | 0.674 | 9 | 9 | 0.753 | 9 | 0.512 | 1 | 7 | 0.269 |
8 | 1.2 | 1.0 | 4 | 1.0 | 0.8 | 3 | 1.1 | 0.8 | |||||||
DrugScore::Pair/Surf | 2 | 0.384 | 8 | 4 | 0.322 | 5 | 0.780 | 9 | 2 | 0.807 | 9 | 0.623 | 0 | 3 | 0.495 |
8 | 1.3 | 1.0 | 4 | 1.3 | 0.9 | 3 | 1.1 | 0.8 | |||||||
Sybyl::D-Score | 2 | 0.342 | 0 | 3 | 0.305 | 5 | 0.617 | 7 | 8 | 0.736 | 9 | 0.584 | 4 | 6 | 0.441 |
8 | 1.3 | 1.0 | 3 | 1.0 | 0.8 | 3 | 1.0 | 0.8 | |||||||
Sybyl::PMF-Score | 2 | 0.246 | 4 | 9 | 0.226 | 7 | 0.513 | 2 | 6 | 0.523 | 9 | 0.655 | 7 | 0 | 0.652 |
8 | 1.3 | 1.0 | 4 | 1.4 | 1.0 | 3 | 1.0 | 0.7 | |||||||
Sybyl::G-Score | 2 | 0.350 | 0 | 5 | 0.335 | 5 | 0.580 | 2 | 6 | 0.728 | 9 | 0.643 | 8 | 9 | 0.649 |
8 | 1.2 | 1.0 | 4 | 1.1 | 0.9 | 3 | 1.1 | 0.7 | |||||||
Sybyl::ChemScore | 2 | 0.376 | 8 | 5 | 0.350 | 5 | 0.761 | 3 | 1 | 0.749 | 9 | 0.609 | 2 | 6 | 0.663 |
8 | 1.3 | 1.0 | 4 | 1.3 | 1.0 | 3 | 1.1 | 0.8 | |||||||
Sybyl::F-Score | 0 | 0.361 | 1 | 8 | 0.375 | 5 | 0.663 | 1 | 5 | 0.610 | 5 | 0.371 | 5 | 7 | 0.145 |
8 | 1.1 | 0.9 | 4 | 1.5 | 1.2 | 1 | 1.7 | 1.3 | |||||||
Cerius2::LigScore | 1 | 0.528 | 8 | 9 | 0.496 | 0 | 0.392 | 9 | 7 | 0.467 | 8 | 0.154 | 8 | 4 | −0.323 |
8 | 1.2 | 1.0 | 4 | 1.1 | 0.8 | 3 | 0.9 | 0.7 | |||||||
Cerius2::PLP1 | 2 | 0.458 | 3 | 2 | 0.395 | 5 | 0.729 | 9 | 8 | 0.785 | 9 | 0.718 | 8 | 6 | 0.606 |
8 | 1.2 | 1.0 | 4 | 1.1 | 0.8 | 3 | 0.9 | 0.6 | |||||||
Cerius2::PLP2 | 2 | 0.438 | 5 | 3 | 0.414 | 5 | 0.754 | 5 | 4 | 0.802 | 9 | 0.735 | 6 | 7 | 0.781 |
8 | 1.2 | 1.0 | 4 | 1.0 | 0.8 | 3 | 1.1 | 0.8 | |||||||
Cerius2::PMF | 2 | 0.411 | 6 | 3 | 0.342 | 3 | 0.775 | 6 | 5 | 0.740 | 9 | 0.604 | 2 | 7 | 0.603 |
8 | 1.3 | 1.1 | 4 | 1.2 | 1.0 | 3 | 1.2 | 0.8 | |||||||
Cerius2::LUDI1 | 2 | 0.208 | 5 | 1 | 0.123 | 5 | 0.670 | 9 | 1 | 0.698 | 8 | 0.065 | 1 | 6 | 0.335 |
8 | 1.3 | 1.1 | 4 | 1.2 | 0.9 | 3 | 1.2 | 0.8 | |||||||
Cerius2::LUDI2 | 2 | 0.274 | 3 | 1 | 0.181 | 5 | 0.696 | 5 | 5 | 0.725 | 9 | 0.470 | 5 | 9 | 0.519 |
8 | 1.3 | 1.1 | 4 | 1.2 | 1.0 | 3 | 1.2 | 0.9 | |||||||
Cerius2::LUDI3 | 2 | 0.248 | 4 | 0 | 0.174 | 5 | 0.679 | 8 | 0 | 0.690 | 9 | 0.433 | 7 | 1 | 0.554 |
6 | 1.2 | 1.0 | 3 | 1.6 | 1.3 | 3 | 1.2 | 0.9 | |||||||
GOLD::GoldScore | 9 | 0.386 | 5 | 0 | 0.391 | 6 | 0.029 | 5 | 2 | −0.012 | 4 | 0.539 | 5 | 0 | 0.420 |
7 | 11 | 0.9 | 4 | 1.4 | 1.1 | 3 | 1.1 | 0.8 | |||||||
GOLD::GoldScore_opt | 8 | 0.555 | 3 | 2 | 0.579 | 2 | 0.590 | 1 | 4 | 0.673 | 7 | 0.585 | 7 | 6 | 0.532 |
7 | 1.1 | 0.9 | 4 | 1.6 | 1.3 | 3 | 1.2 | 0.8 | |||||||
GOLD::ChemScore | 8 | 0.404 | 9 | 8 | 0.386 | 4 | 0.388 | 1 | 3 | 0.348 | 9 | 0.498 | 2 | 9 | 0.307 |
8 | 1.2 | 1.0 | 4 | 1.4 | 1.2 | 3 | 1.0 | 0.8 | |||||||
GOLD::ChemScore_opt | 0 | 0.429 | 4 | 2 | 0.393 | 4 | 0.520 | 9 | 1 | 0.565 | 9 | 0.639 | 8 | 0 | 0.454 |
8 | 1.3 | 1.0 | 4 | 1.7 | 1.3 | 3 | 1.1 | 0.7 | |||||||
HINT | 2 | 0.313 | 2 | 4 | 0.264 | 5 | 0.135 | 3 | 7 | 0.251 | 9 | 0.599 | 3 | 8 | 0.689 |
Affinities
The 2002 version of PDBbind was categorized into 3 groups: low-affinity (pKd < 5), medium-affinity (5 ≤ pKd ≤ 8), and high-affinity (pKd > 8). PHOENIX was assessed on its ability to calculate a binding affinity that results in the same group as the experimental binding affinity. Results from this study are listed in Table 8. PHOENIX correctly categorized 27% of the low-affinity complexes, 100% of the medium-affinity complexes, and 61% of the high-affinity complexes. PHOENIX performed the best on the medium- and high-affinity complexes compared to the scoring functions from previous studies. The performance on the low-affinity group was the second best (best was SFCscore). This assessment demonstrated that PHOENIX can estimate affinities within a reasonable accuracy range to readily distinguish between a tight-binding ligand from a low-affinity ligand. As minimizing false-positive rates is a significant challenge in computer-aided molecular design, PHOENIX may prove to be advantageous for affinity estimations and relative rankings as well as binding pose prediction, especially when applied to high-resolution structures with high-quality experimental data.
Table 8.
Scoring Function | Low | Medium | High |
---|---|---|---|
PHOENIX | 52/205=27% | 417/417=100% | 112/193=61% |
SFSscore::met | 88/191=46% | 309/417=74% | 86/192=45% |
X-Score::HPScore | 33/205=16% | 358/402=89% | 48/193=25% |
X-Score::HMScore | 41/205=20% | 348/402=87% | 65/193=34% |
X-Score::HSScore | 29/205=14% | 350/402=87% | 53/193=27% |
DrugScore::Pair | 24/205=12% | 359/402=89% | 45/193=23% |
DrugScore::Surf | 11/205=5% | 362/402=90% | 45/193=23% |
DrugScore::Pair/Surf | 24/205=12% | 358/402=89% | 47/193=24% |
Sybyl::D-Score | 0/205=0% | 384/402=96% | 2/193=1% |
Sybyl::PMF-Score | 0/196=0% | 395/396=99% | 0/193=0% |
Sybyl::G-Score | 12/205=6% | 359/402=89% | 30/193=16% |
Sybyl::ChemScore | 38/204=19% | 349/400=87% | 40/193=21% |
Sybyl::F-Score | 0/182=0% | 362/362=100% | 0/188=0% |
Cerius2::LigScore | 11/186=6% | 340/366=93% | 16/165=10% |
Cerius2::PLP1 | 24/205=12% | 364/401=91% | 35/193=18% |
Cerius2::PLP2 | 30/205=15% | 363/402=90% | 32/193=17% |
Cerius2::PMF | 0/202=0% | 390/400=97% | 3/193=2% |
Cerius2::LUDI1 | 1/203=0% | 379/394=96% | 9/193=5% |
Cerius2::LUDI2 | 6/205=3% | 378/401=94% | 15/193=8% |
Cerius2::LUDI3 | 1/205=0% | 387/402=96% | 9/193=5% |
GOLD::GoldScore | 0/178=0% | 331/339=98% | 4/177=2% |
GOLD::GoldScore_opt | 3/200=1% | 366/385=95% | 11/187=6% |
GOLD::ChemScore | 8/177=5% | 345/376=92% | 37/188=20% |
GOLD::ChemScore_opt | 20/187=11% | 346/386=90% | 38/189=20% |
HINT | 2/205=1% | 388/402=97% | 11/193=6% |
Recent versions of PDBbind
Recent versions of the PDBbind dataset (2004 and 2009) were used as external test sets for scoring function validation. The correlation statistics for the 2004 version (n = 1073), also used as a test set in the development of SFCscore, are listed in Table 8, and the ones for the 2009 version (n = 1612) are listed in Table 9. Based on the results from the 2004 and 2009 “refined sets”, PHOENIX demonstrated comparable performance compared with the X-Score functions and SFCscore (the better performing scoring functions). Also, results from the larger and more diverse 2004 and 2009 PDBbind refined sets demonstrated the robustness of PHOENIX in predicting affinities for various types of protein-ligand interactions.
Table 9.
Scoring Function | Rp | Rs | SD | ME | a | b |
---|---|---|---|---|---|---|
PHOENIX | 0.515 | 0.554 | 2.00 | 1.57 | 0.35 | 4.46 |
X-Score::HPScore | 0.557 | 0.589 | 2.00 | 1.57 | 0.32 | 4.24 |
X-Score::HMScore | 0.540 | 0.572 | 2.06 | 1.63 | 0.29 | 4.23 |
X-Score::HSScore | 0.561 | 0.593 | 1.95 | 1.53 | 0.36 | 4.27 |
Diverse and non-redundant test set
To further assess the performance of PHOENIX compared with other scoring functions, the PDBbind 2007 core set was used to represent a diverse, yet non-redundant, set of protein-ligand complexes. The 2007 core set includes 65 unique protein family members, each with a low-, medium-, and high-affinity ligand. Binding affinities ranged from 1.40 to 13.96 pKd, molecular weight from 103 to 974, and number of ligand rotatable bonds from 0 to 32. Performance in the “scoring power” test similar to the Cheng et al. study was used to assess PHOENIX. The statistics from correlation evaluation on affinity predictions are listed in Table 10. To test whether scoring functions provided value over the use of a simple descriptor, the number of heavy atoms was assessed as a scoring method. PHOENIX resulted in the second highest Pearson correlation coefficient, however, the mean error was more than twice as large as the second largest (1.70 compared to 0.71), suggesting that there is still significant room for improvement in the accuracy of affinity predictions.
Table 10.
Scoring Function | Rp | Rs | SD | ME | a | b |
---|---|---|---|---|---|---|
PHOENIX | 0.575 | 0.591 | 1.76 | 1.41 | 0.44 | 3.98 |
X-Score::HPScore | 0.571 | 0.589 | 1.78 | 1.43 | 0.36 | 4.05 |
X-Score::HMScore | 0.563 | 0.581 | 1.84 | 1.48 | 0.34 | 4.03 |
X-Score::HSScore | 0.565 | 0.584 | 1.75 | 1.42 | 0.40 | 4.10 |
To assess the “ranking power” of PHOENIX as performed in the Cheng et al. study, each of the 65 families were assessed to check if the low-, medium-, and high-affinity ligand were ranked in the correct order. Families that were ranked correctly for all 3 complexes were given a score of 1, while a score of 0 is given if there is any deviation from the correct ranking (e.g, low, high, medium; medium, high, low). The success rate in the “ranking power” study of the 2007 core set is listed in Table 11. PHOENIX achieved a success rate of 46.2%, which ranks amongst the best-performing functions, with only 4 other scoring functions with a higher success rate (X-Score::HSscore, 58.5%; DS::PLP2, 53.8%; DrugScoreCSD, 52.3%; SYBYL::ChemScore, 47.7%). The performance of PHOENIX in this study demonstated its utility in structure-based design to correctly rank relative affinities for various types of protein-ligand complexes.
Table 11.
Scoring Function | N | Rp | SD | ME |
---|---|---|---|---|
PHOENIX | 194 | 0.616 | 2.16 | 0.644 |
X-Score::HMScore | 195 | 0.644 | 1.83 | 0.705 |
DrugScoreCSD | 195 | 0.569 | 1.96 | 0.627 |
SYBYL::ChemScore | 195 | 0.555 | 1.98 | 0.585 |
DS::PLP1 | 195 | 0.545 | 2.00 | 0.588 |
GOLD::ASP | 193 | 0.534 | 2.02 | 0.577 |
SYBYL::G-Score | 195 | 0.492 | 2.08 | 0.536 |
DS::LUDI3 | 195 | 0.487 | 2.09 | 0.478 |
DS::LigScore2 | 193 | 0.464 | 2.12 | 0.507 |
GlideScore-XP | 178 | 0.457 | 2.14 | 0.435 |
DS::PMF | 193 | 0.445 | 2.14 | 0.448 |
GOLD::ChemScore | 178 | 0.441 | 2.15 | 0.452 |
Number of Heavy Atoms |
195 | 0.431 | 2.15 | 0.517 |
SYBYL::D-Score | 195 | 0.392 | 2.19 | 0.447 |
DS::Jain | 189 | 0.316 | 2.24 | 0.346 |
GOLD::GoldScore | 169 | 0.295 | 2.29 | 0.322 |
SYBYL::PMF-Score | 190 | 0.268 | 2.29 | 0.273 |
SYBYL::F-Score | 185 | 0.216 | 2.35 | 0.243 |
PHOENIX scoring function
The final PHOENIX scoring functions (used to predict ΔH, TΔS, and ΔG (ΔH-TΔS)) that resulted in the best performance across multiple versions (2002, 2004, 2009 refined sets; 2007 core set) and subsets (resolutions, protein families, affinities from v2002) of the PDBbind database used a training set of 112 structurally and energetically diverse complexes. A set of 42 descriptors were included in the ΔH, TΔS, and ΔG (ΔH-TΔS) models: 34 derived from molecular mechanics calculations, various surface area terms, hydrogen-bond donors and acceptor count from VALIDATE; 1 to estimate the ligand partition coefficient (XlogP); 7 shape- and volume-based descriptors from FPOCKET to better capture entropic contributions. Partial least squares was used to assign coefficients to each of the terms to derive the “master equation” to calculate ΔH, TΔS, and ΔG. While change in enthalpy (ΔH) and change in entropy (TΔS) predictions were of limited accuracy (standard errors of ~6 kcal/mol) individually, the difference between their individual predictions resulted in a relatively accurate change in binding free energy (ΔG) (standard errors of 1.5 kcal/mol). External validation using the 2009 version of the PDBbind “refined set” (n = 1612) (most comprehensive high-quality data set for assessing scoring functions) resulted in a Pearson correlation coefficient (Rp) of 0.575 and a mean error (ME) of 1.41 pKd, which demonstrated its relative accuracy and robustness in predicting binding affinities.
DISCUSSION
Predicting binding affinity of protein-ligand interactions remains one of the most critical and challenging problems in computer-aided drug design. The PHOENIX scoring function, derived using a training set of high-resolution structures (n = 112) and calorimetry measurements for change of enthalpy (ΔH) and change of entropy (TΔS) from ITC, has demonstrated an ability to achieve accurate binding affinity predictions across 4 large and diverse sets of protein-ligand complexes (PDBbind 2002, 2004, 2009 refined sets; 2007 core set) using a modest number of descriptors (n = 42) to capture key physicochemical interactions. Nine descriptors contributing the most (>4%) to binding free energy (mean local hydrophobic density, flexibility index, receptor total buried donor/acceptor count, pocket volume, electrostatic interaction energy, hydrophobic/hydrophilic contact surface area 2, proportion of apolar alpha spheres, hydrophobic hydrophilic contact surface area 1, polarity score) aimed to capture the key physical forces underlying protein-ligand interactions: enthalpic contributions via van der Waals interactions, hydrogen bonding at the binding site, electrostatics for specificity; entropic contributions via volume and polarity features of binding site and ligand conformational entropy. Overall, the relative contributions from each of the descriptors were fairly distributed (ranging from 0.001 to 0.072), which suggested that each descriptor contains some degree of information for capturing the physics of protein-ligand interactions. Perhaps the use of a larger and more physically-accurate set of descriptors in future studies may help in further capturing the atomic-level details underlying molecular recognition in protein-ligand interactions.
Despite the promising performance in predicting binding affinities, some limitations of PHOENIX have been revealed. The enthalpy (ΔH) and entropy (TΔS) regression and internal cross-validation results suggest that there is significant room for improvement in deriving these equations. The individual thermodynamics parameters (ΔH and TΔS) displayed only modest predictive ability with relatively large errors (6-7 kcal/mol). There are several possible reasons for this. Scoring function would benefit from training on a larger and more structurally and thermodynamically diverse set of complexes. More physically-accurate descriptors are needed to more accurately capture and separate enthalpic and entropic contributions due to entropy/enthalpy compensation. Descriptors that can better separate enthalpic (ΔH) and entropic (TΔS) contributions are needed to derive more accurate independent thermodynamic models. However, developing descriptors to capture primarily enthalpy or entropy is a challenging feat in itself, since any physicochemical interactions that can be experimentally quantitated are correlated and will contain, to some degree, both thermodynamic forces (e.g, flexibility index and total ligand surface area). Inclusion of descriptors to explicitly capture hydrogen bonding interactions may lead to more accurate ΔH predictions. Descriptors to better capture electrostatics interactions such as pi-cation interactions may also help with predicting enthalpy changes. To better quantitate entropic contributions, descriptors to take into account conformational changes of the binding site, such as quantitating the rotatmers of the side chains involved in the complex, may provide a measure of entropy changes from the protein upon ligand binding (entropy-entropy compensation).48 Classifying water molecules in the binding site according to their energetic preferences as a means to model dewetting will be useful for capturing the entropy change upon ligand binding and displacement of binding-site water molecules.49-52 Inclusion of multiple binding modes to better represent conformational and configurational entropy may help to derive more accurate change in entropy (TΔS) models as been demonstrated in theoretical studies.53-57 Moreover, larger sets of high-quality and structurally and thermodynamically diverse protein-ligand complexes will certainly be necessary to achieve more representative statistics for the different protein families and ligand structures.
As presented earlier, the change in enthalpy (ΔH) and change in entropy (TΔS) calculations were of limited relative accuracy. However, the change in binding free energy (ΔG) calculations was within relative accuracy compared with other commonly used scoring functions. The relative accuracy predicted by the ΔG model (difference of ΔH and TΔS model predictions) may have resulted from the cancellation of the overestimated values from independent ΔH and TΔS calculations, since the regression coefficient signs are in the same direction for both forces. Overestimates of ΔH and TΔS may have been due to the high correlation between the physicochemical descriptors used (e.g., “flexibility index” to capture conformational entropy is correlated to terms estimating total ligand surface area to capture van der Waals interactions to enthalpy), which were originally intended to be used to estimate ΔG. In other words, a descriptor used to estimate TΔS contributions (e.g., flexibility index) may also capture, to some degree, the physical forces underlying ΔH contributions (e.g., ligand total surface area). As an attempt to separate ΔH and TΔS descriptors, simpler models using subsets (n = 20-30) of the final descriptors set (n = 42) that are intuitive to contribute qualitatively to each thermodynamic force were used to test if more accurate predictions can be achieved. However, resulting predictions by these “feature selection” models were not as accurate as the predictions calculated using models with the full descriptors set. As mentioned before, descriptors that can better distinguish between ΔH and TΔS contributions should be developed and included in future development of accurate thermodynamically-based scoring functions.
In developing scoring functions, the inherent inaccuracy of the experimental data, which has been highlighted by a number of scoring function and structure-based design studies, remains the culprit to the limited accuracy in binding affinity predictions. In X-ray crystallography, conditions used to induce crystalization are often in dramatic contrast to physiological conditions under which protein-ligand interactions occur. Another potential source of error is from the thermodynamics measurements by ITC. Experiments conducted with ITC have often been performed under varying temperature and buffer conditions (e.g., salt concentration, pH), that may lead to marked variations in the thermodynamics measurements, as recently pointed out by Myszka et al58. Chodera and Dill have also observed large discrepancies in ΔH measurements from ITC (unpublished). Inclusion of such ITC data in the training sets may not necessarily represent the magnitude of thermodynamics forces under physiological conditions. As the use of ITC increases to measure thermodynamics forces in protein-ligand interactions, diverse structural and thermodynamics data performed under homogenous conditions should become available to help alleviate these limitations.
CONCLUSIONS
Towards development of an empirical scoring function to achieve more accurate binding affinity predictions, high-resolutions X-ray crystal structures of protein-ligand complexes and thermodynamic parameters measured by ITC was used to derive models to calculate enthalpic and entropic contributions to binding free energies. Shape and volume-based descriptors were used as a heuristic method to implicitly capture changes in desolvation entropy and ligand configurational entropy. PHOENIX demonstrated accurate binding affinity predictions comparable to the top-performing scoring functions based on an extensive series of tests on the 4 versions of the PDBbind database. To our knowledge, this is the first empirical scoring function developed using thermodynamics parameters from ITC as a strategy to derive regression equations to calculate binding affinity.
Predicting binding affinities is the most critical and also challenging component of structure-based drug design. Often times, a docking program may identify a compound in the native low-energy conformation, but without an accurate scoring function, will be categorized as a non-binder, rendering the docking program of minimal value. Because of the high false-positive and false-negative rates associated with computer-aided drug design methodologies, development of an accurate and reliable scoring function is absolutely necessary for enhancing the performance of these in silico design tools. Development of the PHOENIX scoring function demonstrated the use of high-resolution structural complexes and thermodynamics parameters for model training can be the key advances towards achieving more accurate binding affinity predictions.
Supplementary Material
Table 5.
Scoring Function | N | Rp | SD | ME | a | b |
---|---|---|---|---|---|---|
PHOENIX | 796 | 0.524 | 1.98 | 1.56 | 0.37 | 4.27 |
SFCscore::met | 800 | 0.585 | 1.8 | 1.37 | 0.82 | 1.23 |
X-Score::HPScore | 800 | 0.514 | 1.89 | 1.47 | 0.71 | 2.03 |
X-Score::HMScore | 800 | 0.566 | 1.82 | 1.42 | 0.92 | 1.18 |
X-Score::HSScore | 800 | 0.506 | 1.9 | 1.48 | 0.93 | 1.24 |
DrugScore::Pair | 800 | 0.473 | 1.94 | 1.51 | 4.90E-06 | 4.1 |
DrugScore::Surf | 800 | 0.463 | 1.95 | 1.53 | 7.20E-05 | 4.48 |
DrugScore::Pair/Surf | 800 | 0.476 | 1.94 | 1.5 | 4.70E-06 | 4.09 |
Sybyl::D-Score | 800 | 0.322 | 2.09 | 1.67 | 9.70E-03 | 5 |
Sybyl::PMF-Score | 785 | 0.147 | 2.16 | 1.74 | 6.43E-03 | 5.92 |
Sybyl::G-Score | 800 | 0.443 | 1.98 | 1.56 | 9.13E-03 | 4.34 |
Sybyl::ChemScore | 797 | 0.499 | 1.91 | 1.5 | 9.10E-02 | 3.9 |
Sybyl::F-Score | 732 | 0.141 | 2.19 | 1.77 | 2.10E-02 | 6.06 |
Cerius2::LigScore | 717 | 0.406 | 2 | 1.57 | 0.79 | 4.63 |
Cerius2::PLP1 | 800 | 0.458 | 1.96 | 1.52 | 2.30E-02 | 4.09 |
Cerius2::PLP2 | 800 | 0.455 | 1.96 | 1.53 | 2.60E-02 | 3.93 |
Cerius2::PMF | 795 | 0.253 | 2.13 | 1.71 | 1.10E-02 | 5.37 |
Cerius2::LUDI1 | 790 | 0.334 | 2.08 | 1.66 | 2.60E-03 | 4.88 |
Cerius2::LUDI2 | 799 | 0.379 | 2.04 | 1.62 | 4.20E-03 | 4.28 |
Cerius2::LUDI3 | 800 | 0.331 | 2.08 | 1.67 | 3.20E-03 | 4.68 |
GOLD::GoldScore | 694 | 0.285 | 2.16 | 1.72 | 2.40E-02 | 5.33 |
GOLD::GoldScore_opt | 772 | 0.365 | 2.06 | 1.63 | 3.00E-02 | 4.7 |
GOLD::ChemScore | 741 | 0.423 | 2 | 1.56 | 8.50E-02 | 4.65 |
GOLD::ChemScore_opt | 762 | 0.449 | 1.96 | 1.52 | 8.60E-02 | 4.41 |
HINT | 800 | 0.33 | 2.08 | 1.65 | 0.2 | 6.36 |
Table 12.
Scoring function | Success rate (%) |
---|---|
PHOENIX | 46.2 |
X-Score::HSScore | 58.5 |
DS::PLP2 | 53.8 |
DrugScoreCSD | 52.3 |
SYBYL::ChemScore | 47.7 |
SYBYL::D-Score | 46.2 |
SYBYL::G-Score | 46.2 |
GOLD::ASP | 43.1 |
DS::LUDI3 | 43.1 |
DS::Jain | 41.5 |
DS::PMF | 41.5 |
SYBYL::PMF-Score | 38.5 |
GOLD::ChemScore | 36.9 |
DS::LigScore2 | 35.4 |
GlideScore-XP | 33.8 |
Number of Heavy Atoms |
32.3 |
SYBYL::F-Score | 29.2 |
GOLD::GoldScore | 23.1 |
ACKNOWLEDGMENT
The authors thank Mr. Malcolm Tobias and Dr. Chris Ho of the Center for Computational Biology for significant technical assistance. Gratitude is expressed to Dr. Richard Head and Mr. Daniel Lee for technical assistance, Dr. Chris Waller for access to FRED, Prof. Glen Kellogg and Dr. Ashutosh Tripathi for access and support to VICE, Prof. Anatoly Ruvinsky for access to his entropy quantitation program, Dr. Vincent Le Guilloux for support of FPOCKET, Prof. Rino Ragno for scientific discussions, Dr. John Chodera and Prof. Ken Dill for sharing unpublished results on studies of accuracy of thermodynamic parameter measurements, and Dr. Christina Taylor for critical reading of this manuscript. Y.T.T. was supported by a PhRMA Foundation Predoctoral Fellowship in Informatics. In addition, G.R.M. acknowledges financial support from NIH GM068460 and the Department of Defense (HDTRA1-09-CHEM-BIO-BAA).
Footnotes
SUPPORTING INFORMATION
Supporting information include the PHOENIX training set structural metrics and energetic parameters, list of descriptors and abbreviations, and equations for the statistical and structural metrics used in the manuscript. This information is available free of charge via the Internet at http://pubs.acs.org/.
REFERENCES
- 1.Ajay, Murcko MA. Computational methods to predict binding free energy in ligand-receptor complexes. J. Med. Chem. 1995;38:4953–4967. doi: 10.1021/jm00026a001. [DOI] [PubMed] [Google Scholar]
- 2.Gohlke H, Klebe G. Approaches to the description and prediction of the binding affinity of small-molecule ligands to macromolecular receptors. Angew. Chem. Int. Ed. Engl. 2002;41:2644–2676. doi: 10.1002/1521-3773(20020802)41:15<2644::AID-ANIE2644>3.0.CO;2-O. [DOI] [PubMed] [Google Scholar]
- 3.Kitchen DB, Decornez H, Furr JR, Bajorath J. Docking and scoring in virtual screening for drug discovery: methods and applications. Nat. Rev. Drug. Discov. 2004;3:935–949. doi: 10.1038/nrd1549. [DOI] [PubMed] [Google Scholar]
- 4.Lyne PD. Structure-based virtual screening: an overview. Drug Discovery Today. 2002;7:1047–1055. doi: 10.1016/s1359-6446(02)02483-2. [DOI] [PubMed] [Google Scholar]
- 5.Shoichet BK. Virtual screening of chemical libraries. Nature. 2004;432:862–865. doi: 10.1038/nature03197. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Beveridge DL, Dicapua FM. Free-Energy Via Molecular Simulation - Applications to Chemical and Biomolecular Systems. Ann. Rev. of Biophys. and Biophys. Chem. 1989;18:431–492. doi: 10.1146/annurev.bb.18.060189.002243. [DOI] [PubMed] [Google Scholar]
- 7.Massova I, Kollman PA. Combined molecular mechanical and continuum solvent approach (MM-PBSA/GBSA) to predict ligand binding. Pers. in Drug Disc. and Des. 2000;18:113–135. [Google Scholar]
- 8.Hansson T, Marelius J, Aqvist J. Ligand binding affinity prediction by linear interaction energy methods. J Comput. Aided Mol. Des. 1998;12:27–35. doi: 10.1023/a:1007930623000. [DOI] [PubMed] [Google Scholar]
- 9.Wang JM, Morin P, Wang W, Kollman PA. Use of MM-PBSA in reproducing the binding free energies to HIV-1 RT of TIBO derivatives and predicting the binding mode to HIV-1 RT of efavirenz by docking and MM-PBSA. J Am. Chem. Soc. 2001;123:5221–5230. doi: 10.1021/ja003834q. [DOI] [PubMed] [Google Scholar]
- 10.Jiao D, Golubkov PA, Darden TA, Ren P. Calculation of protein-ligand binding free energy by using a polarizable potential. Proc. Natl. Acad. Sci. 2008;105:6290–6295. doi: 10.1073/pnas.0711686105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Bohm HJ, Stahl M. The use of scoring functions in drug discovery applications. Rev. in Comput. Chem. 2002;18:41–87. [Google Scholar]
- 12.Bohm HJ. The Development of a Simple Empirical Scoring Function to Estimate the Binding Constant for a Protein Ligand Complex of Known 3-Dimensional Structure. J. of Comput.-Aided Mol. Des. 1994;8:243–256. doi: 10.1007/BF00126743. [DOI] [PubMed] [Google Scholar]
- 13.Bohm HJ. Prediction of binding constants of protein ligands: A fast method for the prioritization of hits obtained from de novo design or 3D database search programs. J. of Comput.-Aided Mol. Des. 1998;12:309–323. doi: 10.1023/a:1007999920146. [DOI] [PubMed] [Google Scholar]
- 14.Eldridge MD, Murray CW, Auton TR, Paolini GV, Mee RP. Empirical scoring functions.1. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes. J. of Comput.-Aided Mol. Des. 1997;11:425–445. doi: 10.1023/a:1007996124545. [DOI] [PubMed] [Google Scholar]
- 15.Wang RX, Lai LH, Wang SM. Further development and validation of empirical scoring functions for structure-based binding affinity prediction. J. of Comput.-Aided Mol. Des. 2002;16:11–26. doi: 10.1023/a:1016357811882. [DOI] [PubMed] [Google Scholar]
- 16.Krammer A, Kirchhoff PD, Jiang X, Venkatachalam CM, Waldman M. LigScore: a novel scoring function for predicting binding affinities. J. of Mol. Graphics Modell. 2005;23:395–407. doi: 10.1016/j.jmgm.2004.11.007. [DOI] [PubMed] [Google Scholar]
- 17.Gohlke H, Hendlich M, Klebe G. Knowledge-based scoring function to predict protein-ligand interactions. J. Mol. Biol. 2000;295:337–356. doi: 10.1006/jmbi.1999.3371. [DOI] [PubMed] [Google Scholar]
- 18.SYBYL; version 7.3. Tripos; St. Louis, MO: 2006. [Google Scholar]
- 19.Jones G, Willett P, Glen R. Molecular Recognition of Receptor-sites Using a Genetic Algorithm With a Description of Desolvation. J. Mol. Biol. 1995;245:43–53. doi: 10.1016/s0022-2836(95)80037-9. [DOI] [PubMed] [Google Scholar]
- 20.Jones G, Willett P, Glen R, Leach A, Taylor R. Development and validation of a genetic algorithm for flexible docking. J. Mol. Biol. 1997;267:727–748. doi: 10.1006/jmbi.1996.0897. [DOI] [PubMed] [Google Scholar]
- 21.Gehlhaar DK, Verkhivker GM, Rejto PA, Sherman CJ, Fogel DB, et al. Molecular Recognition of the Inhibitor Ag-1343 by Hiv-1 Protease - Conformationally Flexible Docking by Evolutionary Programming. Chem. & Biol. 1995;2:317–324. doi: 10.1016/1074-5521(95)90050-0. [DOI] [PubMed] [Google Scholar]
- 22.Sotriffer CA, Sanschagrin P, Matter H, Klebe G. SFCscore: Scoring functions for affinity prediction of protein-ligand complexes. Proteins. 2008;73:395–419. doi: 10.1002/prot.22058. [DOI] [PubMed] [Google Scholar]
- 23.Halperin I, Ma BY, Wolfson H, Nussinov R. Principles of docking: An overview of search algorithms and a guide to scoring functions. Proteins-Structure Function and Genetics. 2002;47:409–443. doi: 10.1002/prot.10115. [DOI] [PubMed] [Google Scholar]
- 24.Wang RX, Lu YP, Wang SM. Comparative evaluation of 11 scoring functions for molecular docking. J. of Med. Chem. 2003;46:2287–2303. doi: 10.1021/jm0203783. [DOI] [PubMed] [Google Scholar]
- 25.Stahl M, Rarey M. Detailed analysis of scoring functions for virtual screening. J. Med. Chem. 2001;44:1035–1042. doi: 10.1021/jm0003992. [DOI] [PubMed] [Google Scholar]
- 26.Wang RX, Lu YP, Fang XL, Wang SM. An extensive test of 14 scoring functions using the PDBbind refined set of 800 protein-ligand complexes. J. Chem. Inf. Comput. Sci. 2004;44:2114–2125. doi: 10.1021/ci049733j. [DOI] [PubMed] [Google Scholar]
- 27.Ferrara P, Gohlke H, Price DJ, Klebe G, Brooks CL. Assessing scoring functions for protein-ligand interactions. J. Med. Chem. 2004;47:3032–3047. doi: 10.1021/jm030489h. [DOI] [PubMed] [Google Scholar]
- 28.Warren GL, Andrews CW, Capelli AM, Clarke B, LaLonde J, et al. A critical assessment of docking programs and scoring functions. J. Med. Chem. 2006;49:5912–5931. doi: 10.1021/jm050362n. [DOI] [PubMed] [Google Scholar]
- 29.Cheng TJ, Li X, Li Y, Liu ZH, Wang RX. Comparative Assessment of Scoring Functions on a Diverse Test Set. J. Chem. Inf. Model. 2009;49:1079–1093. doi: 10.1021/ci9000053. [DOI] [PubMed] [Google Scholar]
- 30.Kawasaki Y, Chufan EE, Lafont V, Hidaka K, Kiso Y, et al. How Much Binding Affinity Can be Gained by Filling a Cavity? Chem. Biol. Drug Des. 2010;75:143–151. doi: 10.1111/j.1747-0285.2009.00921.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Freire E. Do enthalpy and entropy distinguish first in class from best in class? Drug Discovery Today. 2008;13:869–874. doi: 10.1016/j.drudis2008.07.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Freire E. A Thermodynamic Approach to the Affinity Optimization of Drug Candidates. Chem. Biol. Drug Des.n. 2009;74:468–472. doi: 10.1111/j.1747-0285.2009.00880.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Lafont V, Armstrong AA, Ohtaka H, Kiso Y, Amzel LM, et al. Compensating enthalpic and entropic changes hinder binding affinity optimization. Chem. Biol. Drug Des. 2007;69:413–422. doi: 10.1111/j.1747-0285.2007.00519.x. [DOI] [PubMed] [Google Scholar]
- 34.Ladbury JE, Klebe G, Freire E. Adding calorimetric data to decision making in lead discovery: a hot tip. Nat. Rev. Drug Disc. 2010;9:23–27. doi: 10.1038/nrd3054. [DOI] [PubMed] [Google Scholar]
- 35.Marlow M, Dogan J, Frederick K, Valentine K, Wand A. The role of conformational entropy in molecular recognition by calmodulin. Nat. Chem. Biol. 2010;6:352–358. doi: 10.1038/nchembio.347. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Roy J, Laughton C. Long-Timescale Molecular-Dynamics Simulations of the Major Urinary Protein Provide Atomistic Interpretations of the Unusual Thermodynamics of Ligand Binding. Biophys. J. 2010;99:218–226. doi: 10.1016/j.bpj.2010.03.055. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Li LW, Dantzer JJ, Nowacki J, O'Callaghan BJ, Meroueh SO. PDBcal: A comprehensive dataset for receptor-ligand interactions with three-dimensional structures and binding thermodynamics from isothermal titration calorimetry. Chem. Biol. Drug Des. 2008;71:529–532. doi: 10.1111/j.1747-0285.2008.00661.x. [DOI] [PubMed] [Google Scholar]
- 38.Olsson TSG, Williams MA, Pitt WR, Ladbury JE. The Thermodynamics of Protein-Ligand Interaction and Solvation: Insights for Ligand Design. J. Mol. Biol. 2008;384:1002–1017. doi: 10.1016/j.jmb.2008.09.073. [DOI] [PubMed] [Google Scholar]
- 39.Head RD, Smythe ML, Oprea TI, Waller CL, Green SM, et al. VALIDATE: A new method for the receptor-based prediction of binding affinities of novel ligands. J. Am. Chem. Soc. 1996;118:3959–3969. [Google Scholar]
- 40.Le Guilloux V, Schmidtke P, Tuffery P. Fpocket: An open source platform for ligand pocket detection. BMC Bioinformatics. 2009;10 doi: 10.1186/1471-2105-10-168. - [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Brunger AT. Free R value: Cross-validation in crystallography. Macromol. Cryst., Pt. B. 1997;277:366–396. doi: 10.1016/s0076-6879(97)77021-6. [DOI] [PubMed] [Google Scholar]
- 42.Blow DM. Rearrangement of Cruickshank's formulae for the diffraction-component precision index. Acta Cryst. Sec. D-Biol. Cryst. 2002;58:792–797. doi: 10.1107/s0907444902003931. [DOI] [PubMed] [Google Scholar]
- 43.Wang RX, Fang XL, Lu YP, Wang SM. The PDBbind database: Collection of binding affinities for protein-ligand complexes with known three-dimensional structures. J. Med. Chem. 2004;47:2977–2980. doi: 10.1021/jm030580l. [DOI] [PubMed] [Google Scholar]
- 44.Wang RX, Fang XL, Lu YP, Yang CY, Wang SM. The PDBbind database: Methodologies and updates. J. Med. Chem. 2005;48:4111–4119. doi: 10.1021/jm048957q. [DOI] [PubMed] [Google Scholar]
- 45.Wang RX, Fu Y, Lai LH. A new atom-additive method for calculating partition coefficients. J. Chem. Inf. Comput. Sci. 1997;37:615–621. [Google Scholar]
- 46.FILTER, version 1.0. OpenEye; Sante Fe, NM: 2008. [Google Scholar]
- 47.Kellogg GE, Semus SF, Abraham DJ. Hint - a New Method of Empirical Hydrophobic Field Calculation for Comfa. J. Comput.-Aided Mol. Des. 1991;5:545–552. doi: 10.1007/BF00135313. [DOI] [PubMed] [Google Scholar]
- 48.Trbovic N, Cho J, Abel R, Friesner R, Rance M, et al. Protein Side-Chain Dynamics and Residual Conformational Entropy. J. Am. Chem. Soc. 2009;131:615–622. doi: 10.1021/ja806475k. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Abel R, Young T, Farid R, Berne B, Friesner R. Role of the active-site solvent in the thermodynamics of factor Xa ligand binding. J. Am. Chem. Soc. 2008;130:2817–2831. doi: 10.1021/ja0771033. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Homans S. Water, water everywhere - except where it matters? Drug Discovery Today. 2007;12:534–539. doi: 10.1016/j.drudis.2007.05.004. [DOI] [PubMed] [Google Scholar]
- 51.Young T, Abel R, Kim B, Berne B, Friesner R. Motifs for molecular recognition exploiting hydrophobic enclosure in protein-ligand binding. Proc. Natl. Acad. Sci. 2007;104:808–813. doi: 10.1073/pnas.0610202104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Wang L, Abel R, Friesner R, Berne B. Thermodynamic Properties of Liquid Water: An Application of a Nonparametric Approach to Computing the Entropy of a Neat Fluid. J. Chem. Theory Comput. 2009;5:1462–1473. doi: 10.1021/ct900078k. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Ruvinsky A, Kozintsev A. New and fast statistical-thermodynamic method for computation of protein-ligand binding entropy substantially improves docking accuracy. J. Comput. Chem. 2005;26:1089–1095. doi: 10.1002/jcc.20246. [DOI] [PubMed] [Google Scholar]
- 54.Stjernschantz E, Oostenbrink C. Improved Ligand-Protein Binding Affinity Predictions Using Multiple Binding Modes. Biophys. J. 2010;98:2682–2691. doi: 10.1016/j.bpj.2010.02.034. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Ruvinsky A. Role of binding entropy in the refinement of protein-ligand docking predictions: Analysis based on the use of 11 scoring functions. J. Comput. Chem. 2007;28:1364–1372. doi: 10.1002/jcc.20580. [DOI] [PubMed] [Google Scholar]
- 56.Lee J, Seok C. A statistical rescoring scheme for protein-ligand docking: Consideration of entropic effect. Proteins. 2008;70:1074–1083. doi: 10.1002/prot.21844. [DOI] [PubMed] [Google Scholar]
- 57.Salaniwal S, Manas E, Alvarez J, Unwalla R. Critical evaluation of methods to incorporate entropy loss upon binding in high-throughput docking. Proteins. 2007;66:422–435. doi: 10.1002/prot.21180. [DOI] [PubMed] [Google Scholar]
- 58.Myszka DG, Abdiche YN, Arisaka F, Byron O, Eisenstein E, et al. The ABRF-MIRG'02 study: assembly state, thermodynamic, and kinetic analysis of an enzyme/inhibitor interaction. J. Biomol. Tech. 2003;14:247–269. [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.